Detalhe da pesquisa
1.
Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
Eur J Clin Microbiol Infect Dis
; 43(1): 33-43, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910269
2.
Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.
Ther Drug Monit
; 46(1): 80-88, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735762
3.
Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies.
Transpl Infect Dis
; 26(2): e14236, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349035
4.
Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy.
Ann Clin Microbiol Antimicrob
; 23(1): 16, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360651
5.
Systematic review on efficacy and safety of empirical versus pre-emptive antifungal therapy among children with febrile neutropenia reveals paucity of data.
Mycoses
; 67(4): e13722, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606896
6.
Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study).
Pediatr Hematol Oncol
; 41(2): 89-102, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655541
7.
Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection.
Pediatr Hematol Oncol
; 41(2): 172-178, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293777
8.
Impact of a Pediatric Emergency Medicine Pharmacist, Institutional Guideline, and Electronic Order Set on Empiric Antimicrobial Use for Febrile Neutropenia.
Pediatr Emerg Care
; 40(2): 151-155, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440312
9.
The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease.
J Cell Mol Med
; 27(4): 506-514, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722317
10.
Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma in elderly: A single center observational study.
Int J Cancer
; 152(9): 1884-1893, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545885
11.
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps.
Curr Opin Oncol
; 35(4): 241-247, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222193
12.
Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.
Ann Hematol
; 102(9): 2607-2616, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186157
13.
Fusariosis in Mexico: A 10-year retrospective series.
Med Mycol
; 61(12)2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944000
14.
An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia.
Pediatr Blood Cancer
; 70(11): e30633, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592047
15.
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
BMC Infect Dis
; 23(1): 106, 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814229
16.
Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
J Pediatr Hematol Oncol
; 45(6): e702-e709, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494607
17.
Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Support Care Cancer
; 31(12): 687, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947888
18.
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy.
Support Care Cancer
; 31(2): 150, 2023 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737558
19.
Outcome of febrile neutropenic patients treated for bacteriuria in hematology.
Support Care Cancer
; 31(2): 102, 2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622445
20.
Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD-a large pragmatic trial.
Support Care Cancer
; 31(10): 598, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770704